UBS downgraded Syensqo shares (EURONEXT:SYENS) to Neutral from Buy and decreased its price target to €54 from €81 following the company’s fourth-quarter 2025 results, the bank said on Tuesday. The move reflects mounting uncertainty about the timing and strength of an earnings recovery in Syensqo’s Specialty Polymers division.
In the quarter, Syensqo reported organic sales in Specialty Polymers were down 13% year-over-year. UBS said the decline was driven by weaker volumes in electronics end markets and pricing pressures in automotive applications. The research house estimated that volumes in the segment fell 11% in the period while prices slipped 2%.
Specialty Polymers represents about 40% of Syensqo’s total sales, making its performance a material influence on the group’s near-term outlook. In response to the Q4 print, UBS reduced its 2026-2028 EBITDA forecasts by an average of 13% per year and cut EPS estimates by roughly 27% per year.
For 2026, UBS now expects group sales to decline 3.5%. The bank breaks that figure down into a 2% volume decrease, a 0.5% price decline and a 1.5% foreign exchange headwind. UBS’s updated forecast for 2026 EBITDA is €1,088 million, which it notes is broadly in line with Syensqo’s management guidance of around €1.1 billion.
UBS highlighted that Syensqo’s Specialty Polymers business has lagged peers on organic sales growth since the second quarter of 2024, with the divergence widening in the fourth quarter of 2025. While Syensqo’s Specialty Polymers volumes fell an estimated 11% in Q4, specialty chemical peers reported volumes up 2% and prices up 1% in the same period, according to UBS.
The bank derived its €54 price target as the average of two valuation approaches: a discounted cash flow valuation of €52 and a sum-of-the-parts valuation of €56. UBS also pointed to an expected average free cash flow yield of about 6% over the next three years as a factor that should provide some support to the shares.
On valuation metrics, Syensqo is projected to trade at a 2026 EV/EBITDA multiple of roughly 6.7 times, which UBS describes as approximately a 35% discount to peers. The combination of weaker near-term operational performance and the reduction in medium-term earnings forecasts underpins the firm’s decision to move the rating to Neutral and lower the price target.
Context for markets: The revision from UBS is focused on the chemicals and specialty materials sector, with particular implications for companies exposed to electronics and automotive end markets where volumes and pricing have proven volatile.